The Annual report 2011: the state of the drugs problem in Europe is ‘one of contrasts’, says the EU drugs agency (EMCDDA). Launched today in Lisbon, the report shows drug use to be relatively stable in Europe, with some positive signs that cocaine use may have peaked and that cannabis use continues to decline among young people. But signs of stability with some of the more established drugs are offset by new threats. Explored in the report are developments in the synthetic drugs market, the rapid appearance of new substances and widespread polydrug use.
Delivering the agency’s annual assessment, EMCDDA Director Wolfgang Gotz said: ‘Europe’s drug policies and responses must now be configured to face the challenges of the next decade’.